These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cellular metabolic activity and electrochemical stability assay of embedded oxidoreductase enzyme confined in the nanospace of a framework exoskeleton.
    Author: Dey T, Hiremath N, Kant V, Sharma RK, Vankayala R, Dutta S.
    Journal: Biomater Sci; 2023 Jul 25; 11(15):5136-5145. PubMed ID: 37350291.
    Abstract:
    In the present study, we sought to reveal how embedding oxidoreductase enzymes in a metal-organic framework influences restoring the biofunctionality when encapsulated within zeolitic imidazolate framework (ZIF-8 and ZIF-90), wherein these biocomposites were explored for their cellular metabolic activity using the (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) (MTT) assay on A549 lung cancer cells and NIH3T3 (mouse fibroblasts) cells. We chose two biocomposites, namely catalase-encapsulated ZIF-8 and ZIF-90, wherein the enzyme was encapsulated at varied loadings through a rapid self-triggered nucleation around the protein surfaces of the enzyme. Interestingly, this embedding pattern of catalase in both ZIF-8 and ZIF-90 depended on the surface chemistry of the enzyme. Cyclic voltammetry (CV) and electrochemical impedance spectroscopy analysis revealed the stability of the encapsulated enzyme in the nanospace of the ZIF-8 and ZIF-90 frameworks. Investigation of the cellular metabolic activity by the MTT assay of Cat@ZIF-8 and Cat@ZIF-90 on the lung cancer cell A549 showed cell viability enhancement in the case of Cat@ZIF-8 at a higher percentage compared to that of Cat@ZIF-90. A similar metabolic activity assay was performed with the internalization of Cat@ZIF-90 for NIH3T3 (mouse fibroblasts) cells. The revealed difference between the MOF compounds was due to the nano-confinement effect in ZIF-8 compared to ZIF-90, which can accelerate the utilization in cellar metabolic activity.
    [Abstract] [Full Text] [Related] [New Search]